Verition Fund Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,140
Closed -$7K 2907
2022
Q3
$7K Buy
15,140
+100
+0.7% +$52 ﹤0.01% 2908
2022
Q2
$6K Buy
+15,040
New +$6.71K ﹤0.01% 2259
2020
Q4
Sell
-100,000
Closed -$35K 1449
2020
Q3
$35K Buy
100,000
+45,000
+82% +$17.4K ﹤0.01% 1014
2020
Q2
$30K Buy
+55,000
New +$26.5K ﹤0.01% 1029

Other funds holding ASXC

Verition Fund Management's ASXC Position: Q4 2022 in Review

Verition Fund Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2022, closing a stake of 15,140 shares — an estimated $7K sold.

Verition Fund Management first reported a position in ASXC in Q2 2020 and held it in 4 quarters. The position peaked at $35K in Q3 2020. 74 funds tracked by Wall St. Rank hold ASXC as of Q4 2022.

  • Verition Fund Management reported no remaining Asensus Surgical, Inc. position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 15,140 Asensus Surgical, Inc. shares in Q4 2022, an estimated $7K.
  • Verition Fund Management first reported a position in Asensus Surgical, Inc. in Q2 2020 and held it in 4 quarters.
  • Verition Fund Management's Asensus Surgical, Inc. position peaked at $35K in Q3 2020.
  • 74 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.